News from sanofi pasteur A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 21, 2011, 12:30 ET Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today data from a new study examining the immunogenicity and ...

Sep 20, 2011, 09:07 ET Sanofi Pasteur fait don à l'OMS d'une souche vaccinale utilisée pour l'éradication de la polio

- Cette souche vaccinale est utilisée dans la production du vaccin oral contre le virus polio de type 3 - Sanofi Pasteur, la division vaccins de...

Aug 11, 2011, 08:00 ET "Sounds of Pertussis" Campaign Makes Times Square Pit Stop

The Sounds of Pertussis(R) Campaign motors into New York City today to rev up the third annual Pertussis Awareness Day with an array of educational...

Jul 18, 2011, 08:58 ET Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that it began shipping its 2011-2012 Fluzone®...

Jul 07, 2011, 12:15 ET Sanofi Pasteur et Merck Vaccines nomment le Dr Jean-Paul Kress, Président de Sanofi Pasteur MSD

-Une solide expérience biopharmaceutiquepour le développement futur de la joint-venture européenne - MSD, dénommé Merck aux Etats-Unis et au Canada...

Jun 28, 2011, 12:15 ET Sanofi Pasteur Commends Winners of International BioGENEius Challenge

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), offers its congratulations to the four winners of the International...

Jun 22, 2011, 10:00 ET Sanofi Pasteur opens $100M R&D centre in Canada

Strategic Canadian asset puts Ontario at the heart of global vaccine innovation To view the Social Media Release, click here:...

May 10, 2011, 08:00 ET FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the U.S. Food and Drug Administration (FDA) has...

Apr 25, 2011, 08:00 ET Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug...

Apr 22, 2011, 05:58 ET Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug...

Feb 23, 2011, 08:30 ET Sanofi Pasteur Supports Polio Eradication at First International Stock Exchange Event

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), today will participate in the first international...

Feb 23, 2011, 04:38 ET Sanofi Pasteur soutient l'effort d'éradication de la polio lors d'une première internationale sur les places boursières

- Sanofi Pasteur solidaire du Rotary International dans la mobilisation pour sauver des vies aux cérémonies du NYSE et d'Euronext Sanofi Pasteur, la...

Feb 21, 2011, 08:00 ET Sanofi Pasteur et l'International Vaccine Institute s'allient contre la dengue

Sanofi Pasteur, la division vaccins du Groupe sanofi-aventis (EURONEXT : SAN et NYSE : SNY), annonce aujourd'hui son alliance avec l'International...

Feb 21, 2011, 07:59 ET Sanofi Pasteur and International Vaccine Institute Partner Against Dengue

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it is partnering with the...

Nov 29, 2010, 09:00 ET Sanofi Pasteur Starts a Phase II Vaccine Trial for Primary Prevention of Clostridium Difficile

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has started its phase II clinical study of a vaccine for...

Nov 09, 2010, 09:00 ET U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur's Investigational Clostridium difficile Vaccine

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug...

Nov 04, 2010, 02:00 ET Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development

- First Phase 3 Study Underway in Australia Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced...

Nov 04, 2010, 02:00 ET La vacuna contra el dengue de Sanofi Pasteur está en fase final de desarrollo clínico

Sanofi Pasteur, la división de vacunas del Grupo sanofi-aventis (EURONEXT: SAN y NYSE: SNY), anunció hoy que su vacuna contra el dengue ya está...

Oct 25, 2010, 08:45 ET Following Positive Phase II Data, Sanofi Pasteur to Conduct Phase III Trials of Quadrivalent Influenza Virus Vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today the results of a clinical trial of...

Oct 25, 2010, 08:45 ET Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today the results of the Phase III...

Oct 08, 2010, 03:00 ET Sanofi Pasteur and U.S. Department of Health and Human Services Enter Into Agreement for Pandemic Vaccine Preparedness

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), has been awarded a three-year contract for $56.94...

Sep 27, 2010, 12:12 ET Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY) announced today that it has signed a binding...

Sep 21, 2010, 01:00 ET Extensión del programa mundial de estudios clínicos de la vacuna contra el dengue de Sanofi Pasteur a Brasil

Sanofi Pasteur, la división vacunas del Grupo Sanofi-aventis, anunció hoy el inicio de un nuevo estudio clínico con niños y adolescentes, en Brasil,...

Sep 14, 2010, 08:00 ET Sanofi Pasteur introduces new option for flu vaccination - tiny needle, same effectiveness as traditional flu shots

TORONTO, Sept. 14 /PRNewswire-FirstCall/ - To view this Social Media Release, please enter the following address in your web browser....

Sep 13, 2010, 01:30 ET FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine Delivered by Intradermal Microinjection

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it has filed a Supplemental...